Abiomed, Inc. operates within the Surgical and medical instruments sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Abiomed with three other
companies in this sector in the United States:
sales of $270.63 million
of which 44%
was Vascular Interventions & Therapies),
of which 41%
was North America Plasma), and
of which 53%
During the year ended March of 2019, sales at
Abiomed were $769.43 million.
increase of 29.6%
versus 2018, when the company's sales were $593.75 million.
This was the fifth consecutive year of sales increases at Abiomed
(and since 2014, sales have increased a total of 319%).